269 related articles for article (PubMed ID: 2860942)
1. Which component of sulphasalazine is active in rheumatoid arthritis?
Pullar T; Hunter JA; Capell HA
Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
[TBL] [Abstract][Full Text] [Related]
3. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
Neumann VC; Taggart AJ; Le Gallez P; Astbury C; Hill J; Bird HA
J Rheumatol; 1986 Apr; 13(2):285-7. PubMed ID: 2873245
[TBL] [Abstract][Full Text] [Related]
4. [Effect of 5-aminosalicylic acid as a constituent of sulfasalazine in the treatment of chronic polyarthritis].
Wörth WD; Müller W
Z Rheumatol; 1986; 45(2):79-82. PubMed ID: 2873695
[TBL] [Abstract][Full Text] [Related]
5. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.
van Hees PA; Bakker JH; van Tongeren JH
Gut; 1980 Jul; 21(7):632-5. PubMed ID: 6107263
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of stress-induced gastric ulcers by sulphasalazine and its constituents (sulphapyridine and 5-aminosalicylic acid) in rats.
Garg GP; Cho CH; Ogle CW
Pharmacology; 1990; 40(6):318-24. PubMed ID: 1978355
[TBL] [Abstract][Full Text] [Related]
7. Active therapeutic moiety of sulphasalazine.
van Hees PA; van Tongeren JH; Bakker JH; van Lier HJ
Lancet; 1978 Feb; 1(8058):277. PubMed ID: 74700
[No Abstract] [Full Text] [Related]
8. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
Bird HA
Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
Klotz U; Maier K; Fischer C; Heinkel K
N Engl J Med; 1980 Dec; 303(26):1499-502. PubMed ID: 6107853
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine.
Rao SS; Cann PA; Holdsworth CD
Scand J Gastroenterol; 1987 Apr; 22(3):332-6. PubMed ID: 2884724
[TBL] [Abstract][Full Text] [Related]
11. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
Pullar T; Hunter JA; Capell HA
Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
[TBL] [Abstract][Full Text] [Related]
12. Which component of sulphasalazine is active in rheumatoid arthritis?
Situnayake RD; McConkey B
Br Med J (Clin Res Ed); 1985 Jul; 291(6488):138. PubMed ID: 2861878
[No Abstract] [Full Text] [Related]
13. Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
Sheldon P; Pell P
Adv Exp Med Biol; 1995; 371B():905-8. PubMed ID: 7502923
[No Abstract] [Full Text] [Related]
14. The effect of sulphasalazine on neutrophil superoxide generation in rheumatoid arthritis.
Bradley SM; le Gallez P; Throughton PR; Gooi HC; Astbury C; Bird HA
Br J Rheumatol; 1997 May; 36(5):530-4. PubMed ID: 9189053
[TBL] [Abstract][Full Text] [Related]
15. Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.
Farr M; Brodrick A; Bacon PA
Rheumatol Int; 1985; 5(6):247-51. PubMed ID: 2906452
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
Astbury C; Taggart AJ; Juby L; Zebouni L; Bird HA
Ann Rheum Dis; 1990 Aug; 49(8):587-90. PubMed ID: 1975737
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
Klotz U
Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
[TBL] [Abstract][Full Text] [Related]
18. Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine.
Giaffer MH; O'Brien CJ; Holdsworth CD
Aliment Pharmacol Ther; 1992 Feb; 6(1):51-9. PubMed ID: 1347468
[TBL] [Abstract][Full Text] [Related]
19. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
Pullar T; Hunter JA; Capell HA
Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
[TBL] [Abstract][Full Text] [Related]
20. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
Rachmilewitz D
BMJ; 1989 Jan; 298(6666):82-6. PubMed ID: 2563951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]